US Stock MarketDetailed Quotes

LIPO Lipella Pharmaceuticals

Watchlist

2.950
-0.260-8.10%

Close Nov 12 16:00 ET

2.920
-0.030-1.02%

Post 17:38 ET

3.57MMarket Cap-604P/E (TTM)

Lipella Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-40.15%-918.14K

-28.86%-1.39M

-72.03%-3.15M

-214.27%-727.71K

-115.28%-689.36K

-12.96%-655.11K

-54.12%-1.08M

-85.10%-1.83M

50.85%-231.56K

-112.18%-320.21K

Net income from continuing operations

39.03%-938.15K

-11.61%-1.19M

-77.81%-4.62M

-89.29%-688.88K

-85.43%-1.32M

-96.76%-1.54M

-44.70%-1.07M

-39.25%-2.6M

5.40%-363.93K

-36.06%-713.79K

Depreciation and amortization

--1.37K

--72

--1.69K

--723

--962

--0

----

Other non cash items

---649

3,619.86%200.65K

1,160.92%121.2K

--0

----

233.37%5.39K

40.65%9.61K

174.29%4.7K

-3.44%1.65K

Change In working capital

-250.01%-62.03K

-170.29%-605.99K

-195.64%-9.11K

-130.98%-39.55K

128.93%213.29K

416.57%41.35K

-13.09%-224.2K

-95.18%9.52K

509.76%127.66K

-64.16%93.17K

-Change in prepaid assets

-114.76%-22.13K

-488.96%-733.6K

197.97%460.63K

243.76%104.82K

113.01%17.22K

201.78%149.98K

185.35%188.61K

-571.10%-470.18K

142.31%30.49K

-102.65%-132.33K

-Change in payables and accrued expense

55.30%-73.54K

137.08%164.04K

-192.59%-548.86K

-178.41%-165.33K

-0.92%223.44K

-222.66%-164.52K

-2,082.16%-442.46K

201.30%592.82K

419.24%210.86K

113.57%225.51K

-Change in other current assets

215.15%38

729.41%214

-518.03%-2.25K

391.18%99

-22,710.00%-2.28K

-118.44%-33

-108.44%-34

-71.43%538

-111.22%-34

-100.63%-10

-Change in other working capital

-39.91%33.6K

-223.44%-36.65K

171.59%81.37K

--20.85K

---25.1K

--55.92K

--29.69K

-264.63%-113.66K

----

Cash from discontinued investing activities

Operating cash flow

-40.25%-918.79K

-28.80%-1.39M

-72.03%-3.15M

-214.27%-727.71K

-115.28%-689.36K

-12.96%-655.11K

-54.12%-1.08M

-85.10%-1.83M

50.85%-231.56K

-112.18%-320.21K

Investing cash flow

Cash flow from continuing investing activities

-104.80%-14.43K

200.00%300.55K

Net PPE purchase and sale

----

---14.43K

----

--0

----

Net investment purchase and sale

----

--0

--14.43K

----

200.00%300.55K

--0

Cash from discontinued investing activities

Investing cash flow

----

-104.80%-14.43K

--0

----

200.00%300.55K

--0

Financing cash flow

Cash flow from continuing financing activities

900.00%200K

-74.49%1.34M

-69.24%1.61M

-250K

-25K

149.82%5.24M

233,138.20%5.24M

Net issuance payments of debt

--0

-200.00%-275K

--0

---250K

---25K

--275K

--0

Net common stock issuance

--0

--200K

--0

----

--0

136.71%4.96M

----

Proceeds from stock option exercised by employees

----

--1.61M

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

900.00%200K

-74.49%1.34M

-69.24%1.61M

--0

---250K

---25K

149.82%5.24M

233,138.20%5.24M

--0

Net cash flow

Beginning cash position

-47.61%2.11M

-35.69%3.29M

262.26%5.12M

1,999.68%2.41M

615.81%3.11M

869.77%4.02M

262.26%5.12M

133.02%1.41M

-94.74%114.77K

-81.38%434.98K

Current changes in cash

-1.51%-918.79K

-7.75%-1.19M

-149.30%-1.83M

-82.35%883.89K

-119.79%-703.8K

-4,497.79%-905.11K

-10.36%-1.1M

359.42%3.71M

750.70%5.01M

-109.55%-320.21K

End cash Position

-61.89%1.19M

-47.61%2.11M

-35.69%3.29M

1,999.68%2.41M

615.81%3.11M

869.77%4.02M

262.26%5.12M

-94.74%114.77K

Free cash flow

-40.25%-918.79K

-28.80%-1.39M

-72.82%-3.16M

-220.50%-742.14K

-115.28%-689.36K

-12.96%-655.11K

-54.12%-1.08M

-85.10%-1.83M

50.85%-231.56K

-112.18%-320.21K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-40.15%-918.14K	-28.86%-1.39M	-72.03%-3.15M	-214.27%-727.71K	-115.28%-689.36K	-12.96%-655.11K	-54.12%-1.08M	-85.10%-1.83M	50.85%-231.56K	-112.18%-320.21K
Net income from continuing operations	39.03%-938.15K	-11.61%-1.19M	-77.81%-4.62M	-89.29%-688.88K	-85.43%-1.32M	-96.76%-1.54M	-44.70%-1.07M	-39.25%-2.6M	5.40%-363.93K	-36.06%-713.79K
Depreciation and amortization	--1.37K	--72	--1.69K	--723	--962	--0	--0	--0	--0	----
Other non cash items	---649	3,619.86%200.65K	1,160.92%121.2K	--0	----	----	233.37%5.39K	40.65%9.61K	174.29%4.7K	-3.44%1.65K
Change In working capital	-250.01%-62.03K	-170.29%-605.99K	-195.64%-9.11K	-130.98%-39.55K	128.93%213.29K	416.57%41.35K	-13.09%-224.2K	-95.18%9.52K	509.76%127.66K	-64.16%93.17K
-Change in prepaid assets	-114.76%-22.13K	-488.96%-733.6K	197.97%460.63K	243.76%104.82K	113.01%17.22K	201.78%149.98K	185.35%188.61K	-571.10%-470.18K	142.31%30.49K	-102.65%-132.33K
-Change in payables and accrued expense	55.30%-73.54K	137.08%164.04K	-192.59%-548.86K	-178.41%-165.33K	-0.92%223.44K	-222.66%-164.52K	-2,082.16%-442.46K	201.30%592.82K	419.24%210.86K	113.57%225.51K
-Change in other current assets	215.15%38	729.41%214	-518.03%-2.25K	391.18%99	-22,710.00%-2.28K	-118.44%-33	-108.44%-34	-71.43%538	-111.22%-34	-100.63%-10
-Change in other working capital	-39.91%33.6K	-223.44%-36.65K	171.59%81.37K	--20.85K	---25.1K	--55.92K	--29.69K	-264.63%-113.66K	----	----
Cash from discontinued investing activities
Operating cash flow	-40.25%-918.79K	-28.80%-1.39M	-72.03%-3.15M	-214.27%-727.71K	-115.28%-689.36K	-12.96%-655.11K	-54.12%-1.08M	-85.10%-1.83M	50.85%-231.56K	-112.18%-320.21K
Investing cash flow
Cash flow from continuing investing activities			-104.80%-14.43K	0				200.00%300.55K	0	0
Net PPE purchase and sale	----	----	---14.43K	----	----	----	----	--0	----	----
Net investment purchase and sale	----	----	--0	--14.43K	----	----	----	200.00%300.55K	--0	--0
Cash from discontinued investing activities
Investing cash flow	----	----	-104.80%-14.43K	--0	----	----	----	200.00%300.55K	--0	--0
Financing cash flow
Cash flow from continuing financing activities	0	900.00%200K	-74.49%1.34M	-69.24%1.61M	0	-250K	-25K	149.82%5.24M	233,138.20%5.24M	0
Net issuance payments of debt	--0	--0	-200.00%-275K	--0	--0	---250K	---25K	--275K	--275K	--0
Net common stock issuance	--0	--200K	--0	----	----	--0	--0	136.71%4.96M	----	----
Proceeds from stock option exercised by employees	----	----	--1.61M	----	----	----	----	--0	----	----
Cash from discontinued financing activities
Financing cash flow	--0	900.00%200K	-74.49%1.34M	-69.24%1.61M	--0	---250K	---25K	149.82%5.24M	233,138.20%5.24M	--0
Net cash flow
Beginning cash position	-47.61%2.11M	-35.69%3.29M	262.26%5.12M	1,999.68%2.41M	615.81%3.11M	869.77%4.02M	262.26%5.12M	133.02%1.41M	-94.74%114.77K	-81.38%434.98K
Current changes in cash	-1.51%-918.79K	-7.75%-1.19M	-149.30%-1.83M	-82.35%883.89K	-119.79%-703.8K	-4,497.79%-905.11K	-10.36%-1.1M	359.42%3.71M	750.70%5.01M	-109.55%-320.21K
End cash Position	-61.89%1.19M	-47.61%2.11M	-35.69%3.29M	-35.69%3.29M	1,999.68%2.41M	615.81%3.11M	869.77%4.02M	262.26%5.12M	262.26%5.12M	-94.74%114.77K
Free cash flow	-40.25%-918.79K	-28.80%-1.39M	-72.82%-3.16M	-220.50%-742.14K	-115.28%-689.36K	-12.96%-655.11K	-54.12%-1.08M	-85.10%-1.83M	50.85%-231.56K	-112.18%-320.21K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data